WASHINGTON – An abuse-resistant form of the powerful but controversial painkiller OxyContin won’t be ready next year as its manufacturer had hoped. The widely prescribed narcotic painkiller is considered important therapy for many patients suffering long-term moderate to severe pain from cancer or other illnesses. Read More
Comments for: Abuse-resistant OxyContin hits development snag
Abuse-resistant OxyContin hits development snag
You may also like
Abuse-resistant OxyContin hits development snag